Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Por Attia, Peter, Phan, Giao Q., Maker, Ajay V., Robinson, Michael R., Quezado, Martha M., Yang, James C., Sherry, Richard M., Topalian, Suzanne L., Kammula, Udai S., Royal, Richard E., Restifo, Nicholas P., Haworth, Leah R., Levy, Catherine, Mavroukakis, Sharon A., Nichol, Geoff, Yellin, Michael J., Rosenberg, Steven A.
Publicado em 2005

Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study

Por Gianfrancesco, Frank D, Pandina, Gahan, Mahmoud, Ramy, Wu, Jasmanda, Wang, Ruey H
Publicado em 2009

ACTR-19. A PHASE 2 STUDY OF TUMOR TREATING FIELDS AND BEVACIZUMAB IN RECURRENT OR PROGRESSIVE MENINGIOMA

Por Kumthekar, Priya, Kruser, Timothy, Sachdev, Sean, Raizer, Jeffrey, Grimm, Sean, Dixit, Karan
Publicado no Neuro Oncol (2017)

Evolutionary basis of a new approach for the treatment of malignant brain tumors: from mice to humans

Por Lowenstein, Pedro R., Castro, Maria G.
Publicado no Clin Immunol (2017)

P04.91 ABC-drug efflux transporters at the blood-brain barrier limit the efficacy of treatment against primary and secondary brain tumors

Por van Tellingen, O, de Gooijer, M C, Buil, L C M, Fan, L, de Vries, N A, Kemper, E M, Citirikkaya, C, Beijnen, J H
Publicado no Neuro Oncol (2018)

TMOD-07. EVALUATING THE POWER OF PATIENT TUMOR-DERIVED ORTHOTOPIC XENOGRAFT (PDOX) MODELS OF PEDIATRIC BRAIN TUMORS TO PREDICT DRUG RESPONSES IN HUMANS

Por Injac, Sarah, Du, Yuchen, Kogiso, Mari, Braun, Frank, Qi, Lin, Lindsay, Holly, Zhao, Sibo, Li, Xiao-Nan
Publicado no Neuro Oncol (2017)

PCLN-02. EVALUATING THE POWER OF PATIENT TUMOR-DERIVED ORTHOTOPIC XENOGRAFT (PDOX) MODELS OF PEDIATRIC BRAIN TUMORS TO PREDICT DRUG RESPONSES IN HUMANS

Por Injac, Sarah, Du, Yuchen, Kogiso, Mari, Braun, Frank, Zhang, Huiyuan, Qi, Lin, Lindsay, Holly, Zhao, Sibo, Li, Xiao-nan
Publicado no Neuro Oncol (2018)

Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors

Por Cozza, Eugene M., Cooper, Timothy K., Budgeon, Lynn R., Christensen, Neil D., Schell, Todd D.
Publicado no Cancer Immunol Immunother (2014)

Outcomes of reirradiation in the treatment of patients with multiple brain metastases of solid tumors: a retrospective analysis

Por Aktan, Meryem, Koc, Mehmet, Kanyilmaz, Gul, Tezcan, Yilmaz
Publicado no Ann Transl Med (2015)

OS6.2 Medulloblastoma recurrence: Improved survival with a metronomic and targeted antiangiogenesis therapy - experience in 
18 patients

Por Slavc, I., Peyrl, A., Azizi, A. A., Gojo, J., Chocholous, M., Czech, T., Dieckmann, K., Haberler, C.
Publicado no Neuro Oncol (2016)

Halofuginone Inhibits Angiogenesis and Growth in Implanted Metastatic Rat Brain Tumor Model—an MRI Study

Por Abramovitch, Rinat, Itzik, Anna, Harel, Hila, Nagler, Arnon, Vlodavsky, Israel, Siegal, Tali
Publicado em 2004

DDIS-05. DEVELOPMENT OF AN INHIBITOR AGAINST MUSASHI-1 AND ITS USE IN BRAIN TUMOR THERAPY

Por Yi, Caihong
Publicado no Neuro Oncol (2017)

Monitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors

Por Leten, Cindy, Trekker, Jesse, Struys, Tom, Roobrouck, Valerie D., Dresselaers, Tom, Vande Velde, Greetje, Lambrichts, Ivo, Verfaillie, Catherine M., Himmelreich, Uwe
Publicado no Stem Cells Int (2016)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors

Por Endersby, Raelene, Whitehouse, Jacqueline, Hii, Hilary, Greenall, Sameer A., Johns, Terrance G., Gottardo, Nicholas G.
Publicado no Neoplasia (2018)

TRTH-32. COMBINATION IMMUNOTHERAPY TO ACTIVATE THE INNATE IMMUNE MICROENVIRONMENT AGAINST PEDIATRIC BRAIN TUMORS

Por Gholamin, Sharareh, Esparza, Rogelio, Cheshier, Samuel, Mitra, Siddhartha
Publicado no Neuro Oncol (2017)

Monitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors

Por Cindy Leten, Jesse Trekker, Tom Struys, Valerie D. Roobrouck, Tom Dresselaers, Greetje Vande Velde, Ivo Lambrichts, Catherine M. Verfaillie, Uwe Himmelreich
Publicado em 2016-01-01

Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors

Por Burger, Michael C., Zeiner, Pia S., Jahnke, Kolja, Wagner, Marlies, Mittelbronn, Michel, Steinbach, Joachim P.
Publicado no PLoS One (2016)

DIPG-07. GENOMIC ANALYSIS METHODS FOR IDENTIFICATION OF CANCER DRIVER PATHWAYS IN CHILDHOOD BRAIN TUMORS

Por Sanders, Lauren, Rose-Dey, Brittany, Beale, Holly, Pfeil, Jacob, Kephart, Ellen, Learned, Katrina, Durbin, Ann, Bjork, Isabel, Currie, Rob, Morozova, Olena, Agnihotri, Sameer, Salama, Sofie, Haussler, David
Publicado no Neuro Oncol (2018)

Surgical Treatment of Brain Tumors in Infants Less than 6 months of Age and Literature Review

Por Lang, Shih-Shan, Beslow, Lauren A., Gabel, Brandon, Judkins, Alex R., Fisher, Michael J., Sutton, Leslie N., Storm, Phillip B., Heuer, Gregory G.
Publicado em 2011

The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery

Por Routman, David M., Bian, Shelly X., Diao, Kevin, Liu, Jonathan L., Yu, Cheng, Ye, Jason, Zada, Gabriel, Chang, Eric L.
Publicado no Cancer Med (2018)